Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Midi Health vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Midi Health logo

Midi Health

7.0
★★★3.5/5

Best for: menopause-focused care with GLP-1 as a metabolic adjunct

Visit Midi Health
VS
Vytora Health logo

Vytora Health

8.4
★★★★4.2/5

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

Visit Vytora Health

Midi Health and Vytora Health are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Vytora Health starts lower at $150/mo versus $164/mo, and Midi Health is the option we'd start with for most patients. Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Midi Health

Self-pay initial visittelehealth visit
$250/mo

Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. UPDATED 2026-08-15: the earlier claim that no compounded medication price is published is NO LONGER TRUE — see the ladder rows below, from /glp1-pricing.

Self-pay continued care visittelehealth visit
$150/mo

Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.

GLP-1 injectable — starting doses (0.1–0.5 mg), 4-week supplyCompounded
$165.9/mo
semaglutide

From /glp1-pricing, headed 'No membership fees. No surprises.' ⚠ EVERY table is labelled '4-week supply', NOT a calendar month, so this is 13 cycles a year and must never be restated as '/mo'. Ladder runs $165.90 (0.1–0.5 mg) to $355.00 (2.5 mg).

Dual-action GLP-1/GIP injectable — starting doses (1.25–2.5 mg), 4-week supplyCompounded
$210/mo
tirzepatide

4-week supply, not a month. Ladder runs $210.00 (1.25–2.5 mg) to $434.00 (13.75–15 mg).

GLP-1 sublingual — starting dose (0.075 mg), 4-week supplyCompounded · oral
$164/mo
semaglutide

4-week supply, not a month. Ladder runs $164.00 (0.075 mg) to $275.00 (0.8 mg).

Dual-action GLP-1/GIP sublingual — starting dose (1 mg), 4-week supplyCompounded · oral
$209/mo
tirzepatide

4-week supply, not a month. Ladder runs $209.00 (1 mg) to $460.00 (7 mg).

Vytora Health

All dosesCompounded
$180/mo
semaglutide
3-mo bundle ($450 billed)Compounded
$150/mo
semaglutide
All dosesCompounded
$249/mo
tirzepatide
3-mo bundle ($599 billed)Compounded
$200/mo
tirzepatide
Brand 5/7.5/10/12.5/15 mgBrand-name
$1399/mo
mounjaro
Brand 2.5/5/7.5/10/12.5/15 mgBrand-name
$1399/mo
zepbound

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Midi Health

Inclusions not disclosed.

Vytora Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Midi Health

7.0/10

Overall

Vytora Health

8.4/10

Value25%

7.0A
vs
B
8.0

Effectiveness25%

7.0A
vs
B
8.5

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

7.3A
vs
B
9.3

Accessibility10%

6.5A
vs
B
8.5

Support10%

7.0A
vs
B
8.4

Features & Coverage

FeatureMidi HealthVytora Health
Starting Price$164/mo$150/mo
Features5 features8 features
States Available5051
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Midi Health

Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. GLP-1 prescribing is offered as a clinician-discretionary metabolic-health adjunct within the menopause care framework — not as a standalone weight-loss product. Accepts commercial insurance but does NOT accept Medicare, Medicaid, or Medi-Cal.

Read our full Midi Health review →

About Vytora Health

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).

Read our full Vytora Health review →

Pros & Cons

Midi Health

What we like

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Watch-outs

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

Vytora Health

What we like

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
  • Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options

Watch-outs

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Our Verdict

Winner: Midi Health

Midi Health is our recommended choice here, particularly for menopause-focused care with GLP-1 as a metabolic adjunct. Vytora Health is a solid alternative, especially if you want compounded or brand-name GLP-1 with named pharmacy partners, 50 states — compare the six-dimension breakdown and pricing below to weigh them for your situation.

Choose Midi Health if…

You want menopause-focused care with GLP-1 as a metabolic adjunct and a starting price around $164/mo.

Choose Vytora Health if…

You want compounded or brand-name GLP-1 with named pharmacy partners, 50 states and a starting price around $150/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.2

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

7.1

MEDVi

Switching between compounded and brand-name GLP-1 through one provider

7.3

Liv Body

Compounded GLP-1 paired with a muscle-preservation supplement stack

Midi Health vs Vytora Health: FAQ

Vytora Health is cheaper. Its lowest ongoing monthly cash price is $150/mo, compared with $164/mo for Midi Health. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
For most people we'd start with Midi Health, especially if you want menopause-focused care with GLP-1 as a metabolic adjunct. Vytora Health is a strong alternative and may suit you better for compounded or brand-name GLP-1 with named pharmacy partners, 50 states — weigh the six-dimension breakdown above to decide which fits your priorities.
Vytora Health covers more — 51 states versus 50.
Midi Health is an affiliate partner (we may earn a commission on sign-ups through our links); Vytora Health is not. Either way, we rank providers editorially with the same scoring framework and disclose every partnership — being a partner does not buy a higher score.
For Semaglutide, Vytora Health is cheaper at $150/mo versus $164/mo at Midi Health.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Midi Health and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.